Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-NDTranslational cancer research

AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway

Read full textPDFCite

Related

  1. Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis
    Zihui Liu, Yiting Gu, Huanfang Fan +6
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyOncologyPLOS
  2. JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
    Jinrun Wang, Yang Liu, Yanze Li +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Benzoylaconine suppresses colorectal cancer progression by modulating the CDK2/MMP2 signaling axis
    Fengyi Li, Ke Zhang, Miao Wang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
  4. RSPO1-LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway.
    Liting Lu, Xiduan Wei, Sai Liu +8
    Neoplasia (New York, N.Y.)Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  5. OLFM4 promotes intrahepatic cholangiocarcinoma progression through a PKM2-glycolysis-histone lactylation feedback loop.
    Shuochen Liu, Kai Cao, Changan Chen +11
    International journal of biological sciencesPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC

Cite

BibTeXRIS
BibTeX
@article{anon2026amot,
  title = {{AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway}},
  journal = {Translational cancer research},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13657822},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway
PY  - 2026
DA  - 2026/08/28
JO  - Translational cancer research
UR  - https://europepmc.org/article/PMC/PMC13657822
SN  - 2218-676X
ER  -